Free Trial
OTCMKTS:NUMIF

Numinus Wellness (NUMIF) Stock Price, News & Analysis

Numinus Wellness logo
C$0.02 -0.01 (-21.57%)
As of 04/25/2025 02:58 PM Eastern

About Numinus Wellness Stock (OTCMKTS:NUMIF)

Key Stats

Today's Range
C$0.02
C$0.02
50-Day Range
C$0.02
C$0.04
52-Week Range
C$0.01
C$0.08
Volume
29,303 shs
Average Volume
89,790 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Numinus Wellness Inc. provides psychedelic-assisted psychotherapy products and services in Canada and the United States. The company operates through Clinical Research Operations, Canadian Clinic Network, and U.S Clinic Network segments. The Clinical Research Operations segment offers clinical research management services to academic institutions and biotechnology companies. The Canadian Clinic Network segment provides clinical services, including traditional therapy and counseling, ketamine-assisted therapies for depression, psychedelic-assisted therapies, mindfulness programs, and virtual psychotherapy services, as well as neurological care services. The US clinic network segment offers psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management services. The company also offers laboratory services, such as the cultivation, production, and extraction of natural Psilocybe and other psychoactive fungi species, the development of proprietary processes and products, methods for controlled psychedelics and development of a pipeline for product development, and protocol development and safety and efficacy studies; lab testing services; and psychedelic-assisted therapy training services. The company was incorporated in 1964 and is headquartered in Vancouver, Canada.

Receive NUMIF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Numinus Wellness and its competitors with MarketBeat's FREE daily newsletter.

NUMIF Stock News Headlines

Numinus Wellness announces CFO transition
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.
Numinus Wellness Inc. Announces CFO Transition
See More Headlines

NUMIF Stock Analysis - Frequently Asked Questions

Numinus Wellness' stock was trading at C$0.03 on January 1st, 2025. Since then, NUMIF shares have decreased by 20.0% and is now trading at C$0.02.
View the best growth stocks for 2025 here
.

Shares of NUMIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medical Care Facilities
Sub-Industry
N/A
Current Symbol
OTCMKTS:NUMIF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (OTCMKTS:NUMIF) was last updated on 4/27/2025 by MarketBeat.com Staff
From Our Partners